Neuland Laboratories Future Growth
Future criteria checks 2/6
Neuland Laboratories is forecast to grow earnings and revenue by 9.2% and 9.3% per annum respectively. EPS is expected to grow by 9% per annum. Return on equity is forecast to be 21.6% in 3 years.
Key information
9.2%
Earnings growth rate
9.0%
EPS growth rate
Pharmaceuticals earnings growth | 18.8% |
Revenue growth rate | 9.3% |
Future return on equity | 21.6% |
Analyst coverage | Low |
Last updated | 19 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2026 | 19,484 | 3,873 | 3,225 | N/A | 2 |
3/31/2025 | 16,387 | 3,188 | 2,772 | N/A | 2 |
3/31/2024 | 15,825 | 3,108 | 2,418 | N/A | 2 |
12/31/2023 | 15,809 | 3,171 | N/A | N/A | N/A |
9/30/2023 | 14,574 | 2,662 | 2,444 | 3,192 | N/A |
6/30/2023 | 13,333 | 2,154 | N/A | N/A | N/A |
3/31/2023 | 11,915 | 1,635 | 1,711 | 2,372 | N/A |
12/31/2022 | 10,406 | 1,008 | N/A | N/A | N/A |
9/30/2022 | 10,078 | 831 | 341 | 1,070 | N/A |
6/30/2022 | 9,720 | 651 | N/A | N/A | N/A |
3/31/2022 | 9,517 | 638 | -373 | 604 | N/A |
12/31/2021 | 9,400 | 593 | N/A | N/A | N/A |
9/30/2021 | 9,489 | 731 | 359 | 1,437 | N/A |
6/30/2021 | 9,324 | 742 | N/A | N/A | N/A |
3/31/2021 | 9,370 | 806 | 840 | 1,894 | N/A |
12/31/2020 | 8,852 | 540 | N/A | N/A | N/A |
9/30/2020 | 8,436 | 384 | 96 | 887 | N/A |
6/30/2020 | 7,884 | 257 | N/A | N/A | N/A |
3/31/2020 | 7,640 | 162 | 85 | 573 | N/A |
12/31/2019 | 7,443 | 321 | N/A | N/A | N/A |
9/30/2019 | 7,120 | 257 | 312 | 899 | N/A |
6/30/2019 | 6,945 | 216 | N/A | N/A | N/A |
3/31/2019 | 6,675 | 164 | 68 | 699 | N/A |
3/31/2018 | 5,284 | 121 | -1,223 | 113 | N/A |
3/31/2017 | 5,789 | 469 | N/A | 387 | N/A |
3/31/2016 | 5,100 | 273 | N/A | 448 | N/A |
3/31/2015 | 4,692 | 159 | N/A | 132 | N/A |
3/31/2014 | 4,657 | 268 | N/A | 488 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 524558's forecast earnings growth (9.2% per year) is above the savings rate (6.7%).
Earnings vs Market: 524558's earnings (9.2% per year) are forecast to grow slower than the Indian market (17.5% per year).
High Growth Earnings: 524558's earnings are forecast to grow, but not significantly.
Revenue vs Market: 524558's revenue (9.3% per year) is forecast to grow slower than the Indian market (9.9% per year).
High Growth Revenue: 524558's revenue (9.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 524558's Return on Equity is forecast to be high in 3 years time (21.6%)